Skip to main content
. 2021 Mar 26;13(4):559. doi: 10.3390/v13040559

Figure 3.

Figure 3

The oncogenic pathways of the HPV due to the activity of the viral oncoproteins E6 and E7 (Bak: Bcl-2 homologous antagonist/killer, FADD: Fas-associated protein with death domain, FLICE: procaspase 8, IAP-2: Interferon regulatory factor 3,CBP/300: CREB binding protein, TADA3: Transcriptional adaptor 3, Tyk2: tyrosine kinase 2).